Invention Grant
- Patent Title: Methods of treatment of eosinophilic bronchitis with an anti-IL-5 antibody
-
Application No.: US16575903Application Date: 2019-09-19
-
Publication No.: US11325972B2Publication Date: 2022-05-10
- Inventor: Fredrick E. Hargreave , Giampietro Ventresca
- Applicant: GLAXOSMITHKLINE LLC
- Applicant Address: US DE Wilmington
- Assignee: GLAXOSMITHKLINE LLC
- Current Assignee: GLAXOSMITHKLINE LLC
- Current Assignee Address: US DE Wilmington
- Agent Cynthia Lan Martin; Duke Fitch
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61K39/395 ; A61P11/00 ; C07K14/54
Abstract:
The present invention relates generally to the methods for the treatment and diagnosis of conditions mediated by IL-5 and excess eosinophil production, and more specifically to mAbs, Fabs, chimeric and humanized antibodies. More particularly, the present invention relates generally to the treatment of eosinophilic bronchitis with an anti-IL-5 antibody or fragment thereof.
Public/Granted literature
- US20200071395A1 METHODS OF TREATMENT Public/Granted day:2020-03-05
Information query
